Huge recurrent gastric neuroendocrine tumor: a second-line chemotherapeutic dilemma
Chemotherapy is considered “state of the art” for the treatment of poorly differentiated neuroendocrine neoplasms. Unfortunately, there is no standard effective post-first-line treatment for relapsing high-grade gastroenteropancreatic neuroendocrine neoplasms. We report the case of a patient with a...
Main Authors: | Maria João Marques Ribeiro, Teresa Alonso, Pablo Gajate, Javier Molina, Arantzazu Barquin, Cristian Perna, Enrique Grande |
---|---|
Format: | Article |
Language: | English |
Published: |
University of São Paulo
2018-03-01
|
Series: | Autopsy and Case Reports |
Subjects: | |
Online Access: | http://www.revistas.usp.br/autopsy/article/view/147148 |
Similar Items
-
Gastric Mixed Neuroendocrine Non-Neuroendocrine Neoplasms: A Western Center Case Series
by: Marcus Fernando Kodama Pertille Ramos, et al.
Published: (2021-06-01) -
Serum lipid levels correlate to the progression of gastric cancer with neuroendocrine immunophenotypes: A multicenter retrospective study
by: Yi Zou, et al.
Published: (2021-01-01) -
A very rare case of neuroendocrine carcinoma of stomach
by: Abhishek Purkayastha, et al.
Published: (2016-01-01) -
Recurrent Mixed Neuroendocrine-Non-Neuroendocrine Neoplasm in the Gallbladder: A Case Report
by: Turki Al-Fayea, et al.
Published: (2021-03-01) -
Incidence and risk factors of gastrointestinal neuroendocrine neoplasm metastasis in liver, lung, bone, and brain: A population‐based study
by: Zhibo Zheng, et al.
Published: (2019-12-01)